Add to ORKGBreast cancer is the most common malignancy in women, with more than 1 million new individuals diagnosed annually [1]. It is now firmly established that the use of adjuvant chemotherapy and/or endocrine therapies in breast cance
textabstractBreast cancer is one of the leading causes of death of women in western countries. It a...
Clinical targeted sequencing allows for the selection of patients expected to have a better treatmen...
Choosing the optimal chemotherapy regimen is still an unmet medical need for breast cancer patients....
Ten years ago gene-expression profiles were introduced to aid adjuvant chemotherapy decision making ...
Ten years ago gene-expression profiles were introduced to aid adjuvant chemotherapy decision making ...
: Gene-expression profiles are a promising development in determining the prognosis of patients with...
Gene expression profile has revolutionised breast cancer treatment. It has paved the way for develop...
ABSTRACT: Breast cancer is a heterogeneous disease. Patient outcome varies significantly, depending ...
Despite improvements in adjuvant chemotherapy regimens in breast cancer; personalised use of specifi...
Adjuvant systemic treatment (AST) has improved outcome for breast cancer patients. However, not ever...
A consensus conference was held in order to provide guidelines for the use of adjuvant therapy in pa...
The standard treatment of hormone receptor positive, HER2 negative early breast cancer (BC) is surge...
Breast cancer (BC) is a heterogeneous disease characterized by different biopathological features, d...
The addition of adjuvant chemotherapy to hormonal therapy is often considered questionable in patien...
Breast cancer is the most frequent malignancy in women worldwide and is curable in ~70–80% of patien...
textabstractBreast cancer is one of the leading causes of death of women in western countries. It a...
Clinical targeted sequencing allows for the selection of patients expected to have a better treatmen...
Choosing the optimal chemotherapy regimen is still an unmet medical need for breast cancer patients....
Ten years ago gene-expression profiles were introduced to aid adjuvant chemotherapy decision making ...
Ten years ago gene-expression profiles were introduced to aid adjuvant chemotherapy decision making ...
: Gene-expression profiles are a promising development in determining the prognosis of patients with...
Gene expression profile has revolutionised breast cancer treatment. It has paved the way for develop...
ABSTRACT: Breast cancer is a heterogeneous disease. Patient outcome varies significantly, depending ...
Despite improvements in adjuvant chemotherapy regimens in breast cancer; personalised use of specifi...
Adjuvant systemic treatment (AST) has improved outcome for breast cancer patients. However, not ever...
A consensus conference was held in order to provide guidelines for the use of adjuvant therapy in pa...
The standard treatment of hormone receptor positive, HER2 negative early breast cancer (BC) is surge...
Breast cancer (BC) is a heterogeneous disease characterized by different biopathological features, d...
The addition of adjuvant chemotherapy to hormonal therapy is often considered questionable in patien...
Breast cancer is the most frequent malignancy in women worldwide and is curable in ~70–80% of patien...
textabstractBreast cancer is one of the leading causes of death of women in western countries. It a...
Clinical targeted sequencing allows for the selection of patients expected to have a better treatmen...
Choosing the optimal chemotherapy regimen is still an unmet medical need for breast cancer patients....